IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

The Indian pharmaceutical sector is expected to maintain its growth, driven by a strategy focused on increasing market share ...

PROVIDENCE — Two Rhode Island men are accused of being high-ranking members of an organized crime ring that made $12.3 ...

Everybody is looking for a great deal on their medications, and Costco can deliver. But this isn't the only reason to choose ...

Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and ...

Wholesale prices for goods around the country in August grew 0.2% in August, matching Wall Street expectations.

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other ARK stocks. Investing comes in all sizes and flavors. For the risk ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

The UK’s “largest independent pure-play pharmaceutical wholesaler” could be sold by its private equity owner Aurelius by the end of the year, the Financial Times has reported. Warehousing giant AAH ...